Popular asthma drugs bring severe warning

FDA Panels to Advise on LABA Study Designs
The FDA is seeking advice this week from two of its advisory committees on how manufacturers of a major group of asthma drugs should study their potential risks.

Beta-2 Receptor Variants Don't Affect LABA Response...
Against expectations, asthma patients with different genotypes for the beta-2 adrenergic receptor all responded well to long-acting beta agonist (LABA) asthma drugs, researchers said.

Asthma drug limits urged
WASHINGTON -- Government health advisers recommended restrictions Thursday on some long-acting asthma drugs, although not Advair, a top-selling medication.

Burt's Bees Free Head to Toe Starter Kit

Lobe Wonder Ear Support Patches For Earrings,...